Priority Date: 07.09.12 (US 201261698390P)

ISOTOPICALLY ENRICHED ARYLSULFONAMIDE CCR3 ANTAGONISTS

  • Application ID: EP13765874
  • Status: EXAMINATION IN PROGRESS

Attorneys

operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1115.74
Headquarter in Cleveland and 38 offices
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 07.09.2012 - Priority Date (US 201261698390P)
  • 13.03.2014 - Publication A1 (WO2014039748)
  • 15.07.2015 - Publication A1 (EP2892884)